Diagnosis and management of pouchitis and ileoanal pouch dysfunction

被引:31
作者
Navaneethan U. [1 ]
Shen B. [1 ]
机构
[1] Pouchitis Clinic, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, Desk A31
关键词
Antibiotics; Endoscopy; Ileal pouch-anal anastomosis; Inflammatory bowel disease; Pouchitis;
D O I
10.1007/s11894-010-0143-y
中图分类号
学科分类号
摘要
Restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) has become the surgical treatment of choice for patients with medically refractory ulcerative colitis (UC) or UC with dysplasia and for the majority of patients with familial adenomatous polyposis. However, UC patients with IPAA are susceptible to inflammatory and noninflammatory sequelae, such as pouchitis, Crohn's disease of the pouch, cuffitis, and irritable pouch syndrome, in addition to common surgery-associated complications, which adversely affect the surgical outcome and compromise health-related quality of life. Pouchitis is the most frequent long-term complication of IPAA in patients with UC, with a cumulative prevalence of up to 50%. Pouchitis may be classified based on the etiology into idiopathic and secondary types, and the management is often different. Pouchoscopy is the most important tool for the diagnosis and differential diagnosis in patients with pouch dysfunction. Antibiotic therapy is the mainstay of treatment for active pouchitis. Some patients may develop dependency on antibiotics, requiring long-term maintenance therapy. Although management of antibiotic-dependent or antibiotic-refractory pouchitis has been challenging, secondary etiology for pouchitis should be evaluated and modified, if possible. © 2010 Springer Science+Business Media, LLC.
引用
收藏
页码:485 / 494
页数:9
相关论文
共 70 条
  • [1] Fazio V.W., Ziv Y., Church J.M., Et al., Ileal pouch-anal anastomosis: Complications and function in 1005 patients, Ann Surg, 222, pp. 120-127, (1995)
  • [2] Sandborn W.J., Pouchitis following ileal pouch-anal anastomosis: Definition, pathogenesis, and treatment, Gastroenterology, 107, pp. 1856-1860, (1994)
  • [3] Coffey J.C., Winter D.C., Neary P., Et al., Quality of life after ileal pouch-anal anastomosis: An evaluation of diet and other factors using the Cleveland Global Quality of Life instrument, Dis Colon Rectum, 45, pp. 30-38, (2002)
  • [4] Stocchi L., Pemberton J.H., Pouch and pouchitis, Gastroenterology Clinics of North America, 30, 1, pp. 223-241, (2001)
  • [5] Hurst R.D., Molinari M., Chung T.P., Et al., Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy, Arch Surg, 131, pp. 497-500, (1996)
  • [6] Ohge H., Furne J.K., Springfield J., Rothenberger D.A., Madoff R.D., Levitt M.D., Association between fecal hydrogen sulfide production and pouchitis, Diseases of the Colon and Rectum, 48, 3, pp. 469-475, (2005)
  • [7] Gosselink M.P., Schouten W.R., Van Lieshout L.M.C., Hop W.C.J., Laman J.D., Ruseler-Van Embden J.G.H., Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG, Diseases of the Colon and Rectum, 47, 6, pp. 876-884, (2004)
  • [8] Ohge H., Furne J.K., Springfield J., Rothenberger D.A., Madoff R.D., Levitt M.D., Association between fecal hydrogen sulfide production and pouchitis, Diseases of the Colon and Rectum, 48, 3, pp. 469-475, (2005)
  • [9] Falk A., Olsson C., Ahrne S., Molin G., Adawi D., Jeppsson B., Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens, Scandinavian Journal of Gastroenterology, 42, 8, pp. 973-985, (2007)
  • [10] Komanduri S., Gillevet P.M., Sikaroodi M., Mutlu E., Keshavarzian A., Dysbiosis in Pouchitis: Evidence of Unique Microfloral Patterns in Pouch Inflammation, Clinical Gastroenterology and Hepatology, 5, 3, pp. 352-360, (2007)